THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Innovative Nucleic Acids Technologies for Analysis, Detection and Treatment
Years
0
Partners
0
Countries
0
Research areas
0
Doctoral candidates
0
Objectives
The overarching goal of INT2ACT is to contribute to the field of nucleic acid therapeutics for personalised medicine by advancing current methodologies for the detection(WP1) andsequencing (WP2), synthesis andanalysis (WP3), and target identificationanddelivery (WP4) of nucleic acids, while training 15 highly qualified researchers (WP5). To reach the project’s goal the following objectives have been stablished:
Develop more sensitive and accurate NAs detection methods for disease markers in liquid biopsies by identifying new RNA-based biomarkers for therapy toxicity and treatment efficacy, developing machine learning (ML) algorithms for faster analysis and results prediction, and optimising colloidal gold nanosensors for pathogen detection